BDSX Q3 2021 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$138M

Q3 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$7M-29.0% YoY

Gross Profit

$4M58.3% margin

Operating Income

-$13M-200.4% margin

Net Income

-$12M-176.3% margin

EPS (Diluted)

$-8.20

QoQ Revenue Growth

-45.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$90M

Total Liabilities

$74M

Stockholders' Equity

$16M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$9M	-29.0%
Gross Profit	$4M	$5M	-28.2%
Operating Income	-$13M	-$6M	-109.8%
Net Income	-$12M	-$9M	-30.2%

Revenue Segments

Diagnostic Tests

$5M77%

Service

$1M23%